BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

627 related articles for article (PubMed ID: 34479542)

  • 1. Considerations of Australian community pharmacists in the provision and implementation of cognitive pharmacy services: a qualitative study.
    Yong FR; Hor SY; Bajorek BV
    BMC Health Serv Res; 2021 Sep; 21(1):906. PubMed ID: 34479542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful implementation and provision of enhanced and extended pharmacy services.
    Hattingh L; Sim TF; Sunderland B; Czarniak P
    Res Social Adm Pharm; 2020 Apr; 16(4):464-474. PubMed ID: 31272922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular disease risk screening by pharmacists: a behavior change wheel guided qualitative analysis.
    Almansour HA; Mekonnen AB; Aloudah NM; Alhawassi TM; Mc Namara K; Chaar B; Krass I; Saini B
    Res Social Adm Pharm; 2020 Feb; 16(2):149-159. PubMed ID: 31027964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation of a mental health medication management intervention in Australian community pharmacies: Facilitators and challenges.
    Hattingh HL; Kelly F; Fowler J; Wheeler AJ
    Res Social Adm Pharm; 2017; 13(5):969-979. PubMed ID: 28583302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanded practice in rural community pharmacy: a macro-, meso and micro-level perspective.
    Taylor S; Cairns A; Glass B
    Rural Remote Health; 2021 Jul; 21(3):6158. PubMed ID: 34304577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A national survey exploring oral healthcare service provision across Australian community pharmacies.
    Freeman CR; Abdullah N; Ford PJ; Taing MW
    BMJ Open; 2017 Sep; 7(9):e017940. PubMed ID: 28963314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacists experience of and perspectives about recruiting patients into a community pharmacy asthma service trial.
    Bertilsson E; Serhal S; Emmerton L; Bosnic-Anticevich S; Krass I; Bereznicki B; Bereznicki L; Armour C; Saini B
    Res Social Adm Pharm; 2021 Mar; 17(3):595-605. PubMed ID: 32448767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation of diabetes screening in community pharmacy - factors influencing successful implementation.
    Siu AHY; Krass I; Mitchell B; McNamara K
    Res Social Adm Pharm; 2021 Sep; 17(9):1606-1613. PubMed ID: 33414090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacist health coaching in Australian community pharmacies: What do pharmacy professionals think?
    Singh HK; Kennedy GA; Stupans I
    Health Soc Care Community; 2020 Jul; 28(4):1190-1198. PubMed ID: 32020737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards the implementation of breastfeeding-related health services in community pharmacies: Pharmacists' perspectives.
    Sim TF; Hattingh HL; Sherriff J; Tee LBG
    Res Social Adm Pharm; 2017; 13(5):980-988. PubMed ID: 28325528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examination of England's New Medicine Service (NMS) of complex health care interventions in community pharmacy.
    Latif A; Waring J; Watmough D; Barber N; Chuter A; Davies J; Salema NE; Boyd MJ; Elliott RA
    Res Social Adm Pharm; 2016; 12(6):966-989. PubMed ID: 26806858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rural pharmacists and stakeholders perspectives of expanded pharmacy practice: A descriptive study.
    Taylor SM; Cairns A; Glass BD
    Aust J Rural Health; 2021 Jun; 29(3):341-353. PubMed ID: 34148266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of hypertension in an Australian community pharmacy setting - patients' beliefs and perspectives.
    Bajorek BV; LeMay KS; Magin PJ; Roberts C; Krass I; Armour CL
    Int J Pharm Pract; 2017 Aug; 25(4):263-273. PubMed ID: 27633151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An in-depth examination of funded and unfunded cognitive pharmaceutical services.
    Tong V; Krass I; Aslani P
    Explor Res Clin Soc Pharm; 2021 Sep; 3():100060. PubMed ID: 35480617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Qualitative exploration of the experiences of community pharmacists delivering the Diabetes MedsCheck service.
    Gargya D; Mirkazemi C; Curtain C
    J Clin Pharm Ther; 2022 Aug; 47(8):1194-1200. PubMed ID: 35322454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community pharmacists' perspectives about the sustainability of professional pharmacy services: A qualitative study.
    Crespo-Gonzalez C; Benrimoj SI; Scerri M; Garcia-Cardenas V
    J Am Pharm Assoc (2003); 2021; 61(2):181-190. PubMed ID: 33262025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the role of renal pharmacists in outpatient dialysis centres: a qualitative study.
    Salgado TM; Moles R; Benrimoj SI; Fernandez-Llimos F
    Int J Clin Pharm; 2012 Aug; 34(4):569-78. PubMed ID: 22538466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A qualitative assessment of a community pharmacy cognitive pharmaceutical services program, using a work system approach.
    Chui MA; Mott DA; Maxwell L
    Res Social Adm Pharm; 2012; 8(3):206-16. PubMed ID: 21824822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacists' experiences and views on providing screening services: An international comparison.
    Alzubaidi H; Namara KM; Saidawi W; Hasan S; Krass I
    Res Social Adm Pharm; 2020 Nov; 16(11):1558-1568. PubMed ID: 32830071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Australian community pharmacy service provision factors, stresses and strains: A qualitative study.
    Yong FR; Hor SY; Bajorek BV
    Explor Res Clin Soc Pharm; 2023 Mar; 9():100247. PubMed ID: 37008896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.